A method for reducing or alleviating one or more conditions or symptoms associated with glutathione deficiency, increased oxidative stress, and/or increased inflammation, comprising: orally administering an effective of amount of S-acetyl-glutathione (SAG) to an individual in need of such treatment
Nitric oxide production tends to decline with age, and this decline has a negative impact on endothelial function
The GLP-1 approach requires less consumer commitment and often gets better results
Brighter skin might be something too far to attain
A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection
Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth